Cancer Epidemiology and Prevention
Cancer epidemiology and prevention is the branch of medical oncology that studies how often cancers occur across populations, what causes them, and how their burden can be reduced before disease becomes incurable. It links population surveillance, the identification of carcinogenic and modifiable exposures, inherited and infectious causes, and the principles of screening and primary prevention into a single framework for cancer control.
Definition
Cancer epidemiology is the study of the distribution and determinants of neoplastic disease in populations; cancer prevention is the application of that knowledge to reduce the incidence, morbidity, and mortality of cancer through control of causes and early detection.
Scope
This area orients the reader to the population-level study of neoplasms: how incidence and mortality are measured through registries, which exposures and host factors raise cancer risk, and how prevention and early detection are reasoned about. It groups five topics — surveillance, modifiable risk factors, prevention and screening principles, hereditary cancer syndromes, and infection-associated malignancies. It frames these as reference knowledge for understanding cancer burden and causation, not as protocols for managing an individual patient.
Sub-topics
Core questions
- How common is each cancer, and how are its incidence and mortality trends measured over time and place?
- Which exposures and host factors cause cancer, and what fraction of cases is potentially avoidable?
- When does early detection of a cancer improve outcomes, and on what principles is a screening programme justified?
- How do inherited susceptibility and chronic infection shape cancer risk in particular individuals and populations?
Key concepts
- Incidence and mortality
- Cancer registry and surveillance
- Carcinogen and modifiable risk factor
- Population attributable fraction
- Primary, secondary, and tertiary prevention
- Screening and early detection
- Hereditary cancer susceptibility
- Infection-attributable cancer
Key theories
- Multistage carcinogenesis
- Cancer arises through an accumulation of genetic and epigenetic alterations acquired over time, which is why incidence rises steeply with age and why interrupting the process at any stage can lower risk.
- Avoidable-fraction framework
- A substantial proportion of cancer is attributable to identifiable, potentially modifiable causes, so estimating attributable fractions guides where prevention can have the largest population effect.
Mechanisms
At the population level, cancer burden reflects the interplay of exposures (tobacco, diet, radiation, infectious agents), host susceptibility (age, inherited variants), and the latent, multistage biology of carcinogenesis described by Hanahan and Weinberg. Because malignant transformation typically requires the accumulation of multiple alterations over years to decades, exposures act probabilistically and with long latency, and prevention works by removing or reducing a cause (primary prevention) or by detecting and removing precursor or early disease before it becomes lethal (secondary prevention). Quantifying how much of the burden each cause contributes — the attributable fraction — is the analytic bridge from epidemiologic observation to prevention policy.
Clinical relevance
Understanding cancer epidemiology underpins how clinicians and public-health practitioners interpret risk, counsel about avoidable exposures, and reason about who might benefit from screening or genetic evaluation. This area describes how cancer burden and causation are established at the population level and is intended as reference orientation; it is not a source of individualized diagnostic or treatment recommendations.
Epidemiology
Cancer is among the leading causes of death worldwide, with GLOBOCAN estimating roughly 20 million new cases and nearly 10 million deaths in 2022, and incidence patterns vary widely by cancer site, sex, age, and region. A large share of this burden is attributable to potentially modifiable factors, which is the empirical basis for prevention as a discipline.
History
Cancer epidemiology matured in the twentieth century as registries, the case-control and cohort designs, and statistical methods made it possible to link exposures to malignancy at scale. Doll and Peto's 1981 estimate of avoidable cancer causes crystallised the idea that much cancer is preventable, and successive global burden estimates have refined the picture. In parallel, molecular work culminating in the hallmarks-of-cancer synthesis tied population observations to mechanistic biology, integrating epidemiology with the science of carcinogenesis.
Key figures
- Richard Doll
- Richard Peto
- Douglas Hanahan
- Robert Weinberg
- Freddie Bray
Related topics
Seminal works
- doll-peto-1981
- hanahan-weinberg-2011
- bray-2024
Frequently asked questions
- How much cancer is preventable?
- Estimates vary by population, but landmark and contemporary analyses attribute a large share of cancers to potentially modifiable factors such as tobacco, diet, obesity, alcohol, radiation, and infection, meaning a substantial fraction is in principle avoidable through prevention.
- What is the difference between cancer epidemiology and cancer prevention?
- Epidemiology measures how often cancers occur and identifies their causes in populations; prevention applies that knowledge to lower cancer incidence and mortality, either by removing causes or by detecting disease early.